Camber Pharmaceuticals Inc.
Overview
Camber Pharmaceuticals Inc. is a leading manufacturer and supplier of generic pharmaceuticals. As a subsidiary of Hetero Drugs, a global pharmaceutical company, Camber is committed to providing high-quality, affordable medicines to improve patient outcomes.
FDA compliance signals
5 FDA enforcement records linked to this company.
- recall — Class I2023-05-17
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
- recall — Class III2022-12-21
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
- recall — Class II2019-03-27
CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient
- recall — Class II2019-03-27
CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient
- recall — Class II2019-03-27
CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.